Perspective Therapeutics, Inc.
CATX· NYSE
Filed Sep 28, 2012 · 10-K · 90 days after period end · 0001144204-12-053737
derived · Computed from the longer spans the company filed.
| Metric | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|
| Revenue | $1.31M | $1.26M |
| Net Income | -$1.21M | -$712.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Sep 28, 2012 · 90 d after period end